Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
1.
Neuroscience ; 352: 180-189, 2017 06 03.
Artículo en Inglés | MEDLINE | ID: mdl-28391012

RESUMEN

Premature or ill full-term infants are subject to a number of noxious procedures as part of their necessary medical care. Although we know that human infants show neural changes in response to such procedures, we know little of the sensory or affective brain circuitry activated by pain. In rodent models, the focus has been on spinal cord and, more recently, midbrain and medulla. The present study assesses activation of brain circuits using manganese-enhanced magnetic resonance imaging (MEMRI). Uptake of manganese, a paramagnetic contrast agent that is transported across active synapses and along axons, was measured in response to a hindpaw injection of dilute formalin in 12-day-old rat pups, the age at which rats begin to show aversion learning and which is roughly the equivalent of full-term human infants. Formalin induced the oft-reported biphasic response at this age and induced a conditioned aversion to cues associated with its injection, thus demonstrating the aversiveness of the stimulation. Morphometric analyses, structural equation modeling and co-expression analysis showed that limbic and sensory paths were activated, the most prominent of which were the prefrontal and anterior cingulate cortices, nucleus accumbens, amygdala, hypothalamus, several brainstem structures, and the cerebellum. Therefore, both sensory and affective circuits, which are activated by pain in the adult, can also be activated by noxious stimulation in 12-day-old rat pups.


Asunto(s)
Mapeo Encefálico , Encéfalo/diagnóstico por imagen , Encéfalo/crecimiento & desarrollo , Cloruros/farmacología , Imagen por Resonancia Magnética , Compuestos de Manganeso/farmacología , Dolor/patología , Factores de Edad , Animales , Animales Recién Nacidos , Modelos Animales de Enfermedad , Femenino , Formaldehído/toxicidad , Procesamiento de Imagen Asistido por Computador , Masculino , Dolor/inducido químicamente , Dimensión del Dolor , Ratas , Factores de Tiempo
2.
Adv Surg ; 31: 1-34, 1997.
Artículo en Inglés | MEDLINE | ID: mdl-9408486

RESUMEN

In conclusion, most of the recent advances in the management of small bowel obstruction consist of developments in the imaging modalities available to assist in the diagnosis itself, particularly with regard to the distinction between partial and complete obstruction. Unfortunately, little progress has been made to enable physicians to detect early, reversible strangulation, and therefore the surgical management of small-bowel obstruction has changed very little over the past 10 years. Because of the inability to detect reversible ischemia, there is a substantial risk of progression to irreversible ischemia (and an inherent rise in morbidity and mortality) when surgery is delayed for an extended period of time, especially in the setting of suspected complete obstruction. However, almost all patients do benefit from an initial 12 to 24 hours of resuscitation and decompression in cases of complete obstruction; resuscitation and decompression can usually be extended for a longer period of time in those patients with partial obstruction who exhibit no signs of progression (Fig 6). It is encouraging, however, that some advances have been made in understanding the pathophysiology and prevention of adhesion formation. Research efforts in the future should continue to focus on these issues as well as on the development of methods to better recognize early signs of strangulation.


Asunto(s)
Obstrucción Intestinal/terapia , Algoritmos , Humanos , Obstrucción Intestinal/diagnóstico por imagen , Obstrucción Intestinal/fisiopatología , Complicaciones Posoperatorias , Recurrencia , Adherencias Tisulares , Tomografía Computarizada por Rayos X
3.
Toxicol Appl Pharmacol ; 99(1): 28-36, 1989 Jun 01.
Artículo en Inglés | MEDLINE | ID: mdl-2727998

RESUMEN

The ability of physostigmine (PHY) and pyridostigmine (PYR) to protect against the segmental synaptic depression caused by sarin was examined in isolated spinal cords from neonatal rats. The monosynaptic reflex was unaffected at concentrations up to 0.1 microM PHY or 0.3 microM PYR but raising the concentrations of either drug produced a concentration-dependent depression of the monosynaptic reflex which could be completely antagonized by atropine. The monosynaptic reflex was depressed by 50% at 0.45 microM PHY and 2 microM PYR with maximal depression occurring at 1 microM PHY (to about 10% of control) and 10 microM PYR (to about 35% of control). Pretreating the cords with 0.1 microM PHY and PYR for 30 min failed to protect against the depressant effects of sarin even though they inhibited total cholinesterase (ChE) by 27 and 21%, respectively. Both PHY and PYR depressed total ChE activity of the spinal cord in a concentration-dependent manner with 50% inhibition of ChE occurring at 0.8 microM. These results suggest that the carbamates affect segmental transmission by activation of a muscarinic receptor, that protective carbamylation of ChE is ineffective against organophosphorus-induced segmental depression, and that inhibition of ChE is unrelated to both carbamate- and organophosphorus-induced depression of the monosynaptic reflex.


Asunto(s)
Inhibidores de la Colinesterasa/toxicidad , Fisostigmina/farmacología , Bromuro de Piridostigmina/farmacología , Reflejo Monosináptico/efectos de los fármacos , Animales , Atropina/farmacología , Relación Dosis-Respuesta a Droga , Femenino , Técnicas In Vitro , Masculino , Embarazo , Ratas , Ratas Endogámicas , Sarín/toxicidad , Médula Espinal/efectos de los fármacos , Médula Espinal/enzimología , Médula Espinal/fisiología
4.
Ann Surg ; 226(3): 324-34; discussion 334-5, 1997 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-9339939

RESUMEN

OBJECTIVE: The authors evaluated the response to extended cervicomediastinal thymectomy as a component of the integrated management of patients with myasthenia gravis in a large series of patients from a single institution. The authors evaluated the response to therapy with respect to a graded, multivariate, ordinal scale chosen to reflect the full range of the disease's manifestations. SUMMARY BACKGROUND DATA: A number of series, of varying sizes, describe the response of patients with myasthenia gravis to thymectomy primarily with respect to the bivariate endpoint of the presence or absence of "remission." These studies fail to describe the full spectrum of postoperative disease severity and have been unable to quantify definitively the influence of putative prognostic variables, nor to assess definitively the statistical significance of apparent improvements over time. METHODS: The authors evaluated 202 consecutive patients who underwent trans-sternal thymectomy for symptomatic myasthenia gravis from 1969 through 1996 at the Johns Hopkins Hospital. The response to surgery, combined with postoperative medical therapy, was evaluated by a standardized scale reflecting the full spectrum of the disease. These data were analyzed by a novel mean multivariate regression analysis, which allowed the quantification of the statistical significance of apparent responses over time and the evaluation of the independent influence of each of nine putative prognostic indicators. RESULTS: There was no perioperative mortality and a 33% perioperative morbidity. There was a marked clinical response at 6 months to 1 year after surgery that was sustained for at least 10 years thereafter. The median increment of improvement was two (of five) classes. Eighty-six percent and 83% of the patients had improved by at least one class at 5 and 10 years, respectively. These changes were statistically significant (p < 0.001). Whereas the use of extended cervicomediastinal thymectomy was associated with a greater than twofold chance of improvement, compared to conventional trans-sternal thymectomy, neither the pathologic diagnosis (presence of thymoma) nor the age at surgery proved to be negative predictors of postoperative response. CONCLUSIONS: Extended cervicomediastinal thymectomy is the procedure of choice as a component of the integrated management of myasthenia gravis, with significant improvement seen in the group as a whole, as well as in subgroups of patients with thymoma and those older than 40 years of age.


Asunto(s)
Miastenia Gravis/cirugía , Timectomía/métodos , Adolescente , Adulto , Anciano , Niño , Intervalos de Confianza , Femenino , Estudios de Seguimiento , Humanos , Masculino , Persona de Mediana Edad , Miastenia Gravis/clasificación , Oportunidad Relativa , Pronóstico , Análisis de Regresión , Reoperación , Factores de Riesgo , Infección de la Herida Quirúrgica/etiología , Tasa de Supervivencia , Timectomía/efectos adversos , Timectomía/mortalidad , Resultado del Tratamiento
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA